Abstract:Background Biliary atresia (BA) is a childhood liver disease characterized by fibrous obstruction and obstruction of the extrahepatic biliary system and is one of the most common and serious biliary disorders in infants. Significant inflammation and fibrosis of the liver and biliary tract are the most prominent features, regardless of the initial damage to the BA. Abnormalities in innate or adaptive immunity have been found in human patients and mouse models of BA. We previously reported that children with BA had abnormal lipid metabolism, including free serum carnitine. Objective To study gene and protein expression levels of the hepatic peroxisome proliferator-activated receptor-α (PPARα) signaling pathway and farnesoid X receptor (FXR) in BA and BA fibrosis, and assess their clinical values. Methods Low expression of PPARα and NR1H4 (FXR) in BA were validated in the Gene Expression Omnibus database. Functional differences were determined by gene set enrichment analysis based on of PPARα and NR1H4 expression. BA patients from GSE46960 were divided into two clusters by using consensus clustering according to PPARα, NR1H4, and SMAD3 expression levels, and immunoinfiltration analysis was performed. Finally, 58 cases treated in our hospital were used for experimental verification. (IHC: 10 Biliary atresia, 10 choledochal cysts; PCR: 10 Biliary atresia, 14 choledochal cysts; WB: 10 Biliary atresia, 4 choledochal cysts). Results Bioinformatics analysis showed that the expression of PPARα, CYP7A1 and NR1H4 (FXR) in the biliary atresia group was significantly lower than in the control group. More BA-specific pathways, including TGFβ signaling pathway, P53 signaling pathway, PI3K-AKT-mTOR signaling pathway, etc., are enriched in BA patients with low PPARα and NR1H4 expression. In addition, low NR1H4 expression is abundant in inflammatory responses, IL6/STAT3 signaling pathways, early estrogen responses, IL2 STAT5 signaling pathways, and TGFβ signaling pathways. The TGFβ signaling pathway was significant in both groups. According to the expression of PPARα, NR1H4 and SMAD3, a key node in TGFβ pathway, BA patients were divided into two clusters using consensus clustering. In cluster 2, SMAD3 expression was high, and PPARα and NR1H4 expression were low. In contrast to cluster 1, immune cell infiltration was higher in cluster 2, which was confirmed by immunohistochemistry. The mRNA and protein levels of PPARα and NR1H4 in BA patients were lower than in the control group by immunohistochemistry, Western blot analysis and real-time PCR. Conclusions The downregulation of PPARα and NR1H4 (FXR) signaling pathway may be closely related to biliary atresia.

Upregulation of High Mobility Group Box 1 May Contribute to the Pathogenesis of Biliary Atresia.

The Aberrant Expression of HLA-DR in Intrahepatic Bile Ducts in Patients with Biliary Atresia: an Immunohistochemistry and Immune Electron Microscopy Study.

CXCL8high Inflammatory B Cells in the Peripheral Blood of Patients with Biliary Atresia Are Involved in Disease Progression

Interleukin-33 overexpression is associated with gamma-glutamyl transferase in biliary atresia.

Metabonomics Reveals Metabolite Changes in Biliary Atresia Infants

Altered T-Cell Receptor β-Chain and Lactate Dehydrogenase Are Associated With the Immune Pathogenesis of Biliary Atresia

Association of T-helper cell cytokine level with age in patients with biliary atresia: a preliminary study.

Immune Characteristics in Biliary Atresia Based on Immune Genes and Immune Cell Infiltration

Identification of Liver Immune Microenvironment-Related Hub Genes in Liver of Biliary Atresia

Progress in Biomarkers Related to Biliary Atresia

Reduced peroxisome proliferator-activated receptor-α and bile acid nuclear receptor NR1H4/FXR may affect the hepatic immune microenvironment of biliary atresia

Elevated Bile Acids In Newborns With Biliary Atresia (Ba)

Distinct Plasma Bile Acid Profiles of Biliary Atresia and Neonatal Hepatitis Syndrome

Histamine is correlated with liver fibrosis in biliary atresia.

Mucosal-associated invariant T cells promote ductular reaction through amphiregulin in biliary atresia

Expression of HSP47 in Liver Tissue and Sera of Infants with Biliary Atresia and Its Correlation with the Degree of Liver Fibrosis and Prognosis

ANKRD1 and SPP1 As Diagnostic Markers and Correlated with Immune Infiltration in Biliary Atresia

Expression of programmed death-1 and its ligands in the liver of biliary atresia

Role of CD56-expressing Immature Biliary Epithelial Cells in Biliary Atresia.

Serum TGF-β1 and VEGF Levels Reflect the Liver Hardness and Function in Children with Biliary Atresia

Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia